中国寄生虫学与寄生虫病杂志 ›› 2020, Vol. 38 ›› Issue (4): 464-468.doi: 10.12140/j.issn.1000-7423.2020.04.011
收稿日期:
2020-04-26
出版日期:
2020-08-30
发布日期:
2020-09-09
通讯作者:
夏志贵
作者简介:
李美(1976-),女,博士,研究员,从事疟疾原虫学研究。E-mail:LI Mei(), XIA Zhi-gui*(), YIN Jian-hai, YAN He
Received:
2020-04-26
Online:
2020-08-30
Published:
2020-09-09
Contact:
XIA Zhi-gui
摘要:
目前全球新型冠状病毒肺炎(COVID-19)疫情不断蔓延,自境外疟疾流行区入境人员存在疟原虫及新型冠状病毒(SARS-CoV-2)双重感染风险,为及时、准确、安全地开展疟疾检测,保障输入性疟疾的早发现、早诊断和早治疗,笔者提出在COVID-19疫情防控期间,疟疾患者血样检测工作中需提高生物安全防护级别、优先采用快速诊断检测(RDT)和核酸检测方法、至少两种检测方法结果一致作为虫种确认依据、实施血片特殊制备的方法等建议,供各临床和疾控实验室参考。
中图分类号:
李美, 夏志贵, 尹建海, 燕贺. 新型冠状病毒肺炎疫情防控期间疟疾患者血样检测的思考和建议[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 464-468.
LI Mei, XIA Zhi-gui, YIN Jian-hai, YAN He. Consideration and recommendations for malaria blood testing during the COVID-19 pandemic[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2020, 38(4): 464-468.
[1] | Zhang L, Feng J, Zhou SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2018[J]. Chin J Parasitol Parasit Dis, 2019,37(3):241-247. (in Chinese) |
( 张丽, 丰俊, 周水森, 等. 2018年全国疟疾疫情特征及消除疟疾工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2019,37(3):241-247.) | |
[2] | Zhang L, Feng J, Zhang SS, et al. The progress of national malaria elimination and epidemiological characteristics of malaria in China in 2017[J]. Chin J Parasitol Parasit Dis, 2018,36(3):201-209. (in Chinese) |
( 张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2018,36(3):201-209.) | |
[3] | Zhang L, Feng J, Zhou SS, et al. Epidemiological characteristics of malaria and the progress towards its elimination in China in 2019[J]. Chin J Parasitol Parasit Dis, 2020,38(2):133-138. (in Chinese) |
( 张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征及消除疟疾工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020,38(2):133-138.) | |
[4] | World Health Organization. WHO coronavirus disease (COVID-19) dashboard[EB/OL]. (2020-07-17)[2020-07-17]. https://covid19.who.int/. |
[5] | National Health Commission of the People’s Republic of China. The technical guidelines for novel coronavirus pneumonia diagnosis and treatment (Version 7)[Z]. Beijing: General Office of the National Health Commission of the People’s Republic of China, 2020. (in Chinese) |
( 中华人民共和国国家卫生健康委办公厅. 新型冠状病毒肺炎诊疗方案(试行第七版)[Z]. 北京: 中华人民共和国国家卫生健康委办公厅, 2020.) | |
[6] | Tang LH, Gao Q, Yu XB, et al. WS 259-2015 Diagnosis of malaria[S]. Beijing: National Health and Family Planning Commission of the People’s Republic of China, 2015. (in Chinese) |
( 汤林华, 高琪, 余新炳, 等. WS 259-2015 疟疾的诊断[S]. 北京: 中华人民共和国卫生和计划生育委员会, 2015.) | |
[7] |
Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety[J]. Transfus Med Rev, 2020,34(2):75-80.
doi: 10.1016/j.tmrv.2020.02.003 pmid: 32107119 |
[8] |
Grant PR, Garson JA, Tedder RS, et al. Detection of SARS coronavirus in plasma by real-time RT-PCR[J]. N Engl J Med, 2003,349(25):2468-2469.
doi: 10.1056/NEJM200312183492522 pmid: 14681520 |
[9] |
Ng EK, Hui DS, Chan KC, et al. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome[J]. Clin Chem, 2003,49(12):1976-1980.
doi: 10.1373/clinchem.2003.024125 pmid: 14633867 |
[10] |
Ng EK, Ng PC, Hon KL, et al. Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severeacute respiratory syndrome[J]. Clin Chem, 2003,49(12):2085-2088.
doi: 10.1373/clinchem.2003.024588 pmid: 14633884 |
[11] |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan[J]. Lancet, 2020,395(10223):497-506.
doi: 10.1016/S0140-6736(20)30183-5 pmid: 31986264 |
[12] | Disease Prevention and Control Bureau of National Health Commission of the People’s Republic of China. The technical guidelines for control novel coronavirus pneumonia (Version 2) Annex 4: guidelines for laboratory testing of new coronavirus pneumonia samples (Version 2)[Z]. Beijing: Disease Prevention and Control Bureau of National Health Commission of the People’s Republic of China, 2002. (in Chinese) |
( 中华人民共和国国家卫生健康委疾病预防控制局. 新型冠状病毒感染的肺炎防控方案(第二版) 附件4: 新型冠状病毒感染的肺炎实验室检测技术指南(第二版)[Z]. 北京: 中华人民共和国国家卫生健康委疾病控制局, 2020. | |
[13] |
Doremalen NV, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as compared with SARS-CoV-1[J]. N Engl J Med, 2020,382(16):1564-1567.
doi: 10.1056/NEJMc2004973 pmid: 32182409 |
[14] |
Mullis L, Saif LJ, Zhang YB, et al. Stability of bovine coronavirus on lettuce surfaces under household refrigeration conditions[J]. Food Microbiol, 2012,30(1):180-186.
doi: 10.1016/j.fm.2011.12.009 |
[15] |
Liu Y, Ning Z, Chen Y, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals[J]. Nature, 2020,582(7813):557-560.
doi: 10.1038/s41586-020-2271-3 pmid: 32340022 |
[16] | Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents[J]. J Hospit Infect, 2020,104(3):246-251. |
[17] |
Rabenau HF, Cinatl J, Morgenstern B, et al. Stability and inactivation of SARS coronavirus[J]. Med Microbiol Immunol, 2005,194(1/2):1-6.
doi: 10.1007/s00430-004-0219-0 |
[18] | Zou Y, Zheng YS, Cao J. Suggestions for standardizing the process of malaria diagnosis and treatment during the epidemic control of coronavirus disease (COVID-19)[J]. Chin J Parasitol Parasit Dis, 2020,38(1):1-4. (in Chinese) |
( 邹洋, 郑以山, 曹俊. 新型冠状病毒肺炎防控期间规范疟疾诊疗流程的建议[J]. 中国寄生虫学与寄生虫病杂志, 2020,38(1):1-4.) | |
[19] | General Office of the National Health Commission of the People’s Republic of China. Biological safety guidelines for laboratory testing novel coronavirus (Version 2)[Z]. Beijing: General Office of the National Health Commission of the People’s Republic of China, 2020. (in Chinese) |
( 中华人民共和国国家卫生健康委办公厅. 新型冠状病毒实验室生物安全指南(第二版)[Z]. 北京: 中华人民共和国国家卫生健康委办公厅, 2020.) | |
[20] |
Lei L, Liu XS, Mao LL, et al. Evaluation of three testing methods on the diagnosis of malaria[J]. Chin J Vector Biol Control, 2015,26(2):206-208. (in Chinese)
doi: 10.11853/j.issn.1003.4692.2015.02.027 |
( 雷露, 刘学升, 毛玲玲, 等. 3种实验室检测方法在疟疾诊断中的应用比较[J]. 中国媒介生物学及控制杂志, 2015,26(2):2016-210.) | |
[21] | Li SH, Gao LJ, Zhang YL, et al. Comprehensive analysis of three detection methods on the laboratory diagnosis of malaria[J]. Henan J Preve Med, 2018,29(4):252-254, 266. (in Chinese) |
( 李素华, 高丽君, 张雅兰, 等. 3种检测方法在疟疾实验室诊断中的比较分析[J]. 河南预防医学杂志, 2018,29(4):252-254, 266.) | |
[22] | Wang ZY, Jiang L, Zhang YG, et al. Comparative analysis of malaria detection ability of laboratories in Shanghai City from 2012 to 2015[J]. Chin J Schisto Control, 2017,29(3):305-309, 328. (in Chinese) |
( 王真瑜, 江莉, 张耀光, 等. 2012-2015年上海市实验室疟疾检测能力比较分析[J]. 中国血吸虫病防治杂志, 2017,29(3):305-309, 328.) | |
[23] | World Health Organization. Tailoring malaria interventions in the COVID-19 response[EB/OL]. ( 2020-04-03) [2020-04-26]. https://www.who.int/malaria/publications/atoz/tailoring-malaria-interventions-in-the-covid-19-response/en/. |
[24] | China Center for Disease Control and Prevention. Technical program for malaria elimination (Version 2011)[M]. Beijing: Chinese Center for Disease Control and Prevention, 2011. (in Chinese) |
( 中国疾病预防控制中心. 消除疟疾技术方案(2011年版)[M]. 北京: 中国疾病预防控制中心, 2011.) | |
[25] |
Yin JH, Yan H, Huang F, et al. Establishing a China malaria diagnosis reference laboratory network for malaria elimination[J]. Malar J, 2015,14:40.
doi: 10.1186/s12936-015-0556-z pmid: 25628071 |
[26] | Li M, Wang ZY, Zhang T, et al. Exploration of using one-step reverse transcription PCR in detection of four species of human malaria parasite[J]. Chin J Parasitol Parasit Dis, 2016,34(6):500-505. (in Chinese) |
( 李美, 王真瑜, 张淘, 等. 一步反转录PCR技术在检测4种人疟原虫中的初步应用[J]. 中国寄生虫学与寄生虫病杂志, 2016,34(6):500-505.) | |
[27] | Li M, Xia ZG, Tang LH. Establishment and application of multiplex PCR system for detecting four human Plasmodium species[J]. Chin J Parasitol Parasit Dis, 2015,33(2):91-95. (in Chinese) |
( 李美, 夏志贵, 汤林华. 检测4种人体疟原虫多重PCR体系的建立和应用[J]. 中国寄生虫学与寄生虫病杂志, 2015,33(2):91-95.) | |
[28] | Jiang L, Wang ZY, Zhang YG, et al. Analysis on the application of three methods for malaria diagnosis[J]. Chin J Parasitol Parasit Dis, 2015,33(2):91-95. (in Chinese) |
( 江莉, 王真瑜, 张耀光, 等. 3种疟疾检测方法的应用分析[J]. 中国寄生虫学与寄生虫病杂志, 2017,35(1):53-58.) | |
[29] | Ren LZ, Zhang Y. Principle and technology of molecular biology experiment[M]. Beijing: Science Press, 2015. ( in Chinese) |
( 任林柱, 张英. 分子生物学实验原理与技术[M]. 北京: 科学出版社, 2015.) | |
[30] |
Li M, Li Jun, Xia ZG, et al. A combined strategy for screening a clustered mobile population returning from highly endemic areas for Plasmodium falciparum[J]. J Infect Dev Ctries, 2017,11(4):287-293.
doi: 10.3855/jidc.8394 pmid: 28459219 |
[31] | Li M, Xia ZG, Zhou SS. Analysis of inconsistence of Plasmodium detection in some malaria cases[J]. Chin J Parasitol Parasit Dis, 2019,37(4):1-8. (in Chinese) |
( 李美, 夏志贵, 周水森. 疟疾病例复核确认过程中检测结果不一致常见问题分析[J]. 中国寄生虫学与寄生虫病杂志, 2019,37(4):1-8.) | |
[32] |
Dalrymple U, Arambepola R, Gething PW, et al. How long do rapid diagnostic tests remain positive after anti-malarial treatment[J]. Malar J, 2018,17:228.
doi: 10.1186/s12936-018-2371-9 pmid: 29884184 |
[33] |
Baker J, McCarthy J, Gatton M, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests[J]. J Infect Dis, 2005,192(5):870-877.
doi: 10.1086/432010 pmid: 16088837 |
[34] | GMP/HTM/WHO. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions[Z/OL]. Geneva: WHO, 2017[2020-04-22]. https://www.who.int/malaria/publications/atoz/information-note-hrp2-based-rdt/en/. |
[35] |
Darnell ME, Taylor DR. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products[J]. Transfusion, 2006,46(10):1770-1777.
doi: 10.1111/j.1537-2995.2006.00976.x pmid: 17002634 |
[36] | America Center for Disease Control. Guidance for malaria diagnosis in patients suspected of Ebola infection in the United States[EB/OL]. (2015-01-15) [2020-04-22]. https://www. cdc.gov/malaria/new_info/2014/malaria_ebola.htm. |
[1] | 龚艳凤, 李紫芬, 唐乖, 黄美琴, 周炳华, 胡强. 2015—2022年江西省疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(5): 586-592. |
[2] | 耿燕, 兰子尧, 李杨, 戴佳芮, 蔡姗, 卢丽丹, 黄雨婷, 师伟芳, 佘丹娅. 2017—2021年贵州省疟疾疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(3): 384-388. |
[3] | 张丽, 易博禹, 尹建海, 夏志贵. 2022年全国疟疾疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 137-141. |
[4] | 陈朱云, 欧阳榕, 肖丽贞, 林耀莹, 谢汉国, 张山鹰. 福建省疟疾消除后基层监测响应系统现况分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 170-175. |
[5] | 陈志辉, 洪劲, 张荣兵, 杨倩, 叶青, 李建荣, 田荣. 2006—2021年昆明市疟疾流行特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 233-237. |
[6] | 刘建成, 许艳, 王龙江, 孔祥礼, 王用斌, 李曰进. 2015—2021年山东省临沂市输入性疟疾疫情监测分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 249-252. |
[7] | 张耀光, 江莉, 王真瑜, 朱民, 朱倩, 马晓疆, 余晴, 陈健. 2020—2021年上海市7例输入性疟疾病例误判原因分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(1): 68-74. |
[8] | 李素华, 纪鹏慧, 周瑞敏, 贺志权, 钱丹, 杨成运, 刘颖, 鲁德领, 王昊, 张红卫, 赵玉玲. 2015—2019年河南省不同诊断机构疟原虫检测能力评价[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6): 748-753. |
[9] | 李美, 周何军, 夏志贵, 张丽, 涂宏, 尹建海. 2019年全国疟疾血涂片制作质量评估[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6): 754-759. |
[10] | 赵卉, 向征, 周隆参, 潘茂华, 杨照青. 阿莫地喹作为抗疟药的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6): 786-791. |
[11] | 纪鹏慧, 蒋甜甜, 贺志权, 周瑞敏, 李素华, 杨成运, 钱丹, 刘颖, 王昊, 张红卫. 2011—2021年河南省输入性三日疟流行病学特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6): 801-805. |
[12] | 冯宁宁, 陶薇, 冯彤, 甄素娟, 李军, 刘洪斌. 河北省疟疾消除及消除后媒介种群和密度监测结果分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(6): 806-809. |
[13] | 史光忠, 张海亭, 王蒴, 何海波, 程侠, 买买提江·吾买尔, 于琳, 阿衣夏木·克尤木, 赵江山. 新冠肺炎流行期间新疆报告输入性卵形疟1例[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 689-691. |
[14] | 国家传染病医学中心撰写组. 疟疾诊疗指南[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 419-427. |
[15] | 黄媛媛, 姚世杰, 卞致芳, 温易鑫, 郑丽, 曹雅明. 地塞米松对实验性脑型疟小鼠的免疫保护作用[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 446-453. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||